Triazolam in Alzheimer's disease: Pilot study on sleep and memory effects
β Scribed by J.Riley McCarten; Craig Kovera; Melitta K. Maddox; James P. Cleary
- Book ID
- 113226601
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 745 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0091-3057
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The effects of a short-acting benzodiazepine hypnotic, triazolam (0.5 mg), on sleep, performance, and arousal threshold were assessed in 20 male poor sleepers (age 21 +/- 2.37 years). Following in a laboratory screening night, all subjects received placebo for 3 nights (single-blind), ten received t
## Abstract Because there is evidence that central cholinergic mechanisms are depleted in dementia, we studied the effects of central cholinergic augmentation on the memory of 5 patients with Alzheimer disease. Patients received placebo, lecithin, physostigmine, or lecithin plus physostigmine in a